Stocks and Investing Stocks and Investing
Wed, March 10, 2021

Oren Livnat Maintained (AVDL) at Strong Buy with Increased Target to $17 on, Mar 10th, 2021


Published on 2024-10-27 15:54:10 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $15 to $17 on, Mar 10th, 2021.

Oren, nor any peers, have made any analyst calls on AVDL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources